Victory Capital Management Inc. Has $1.24 Million Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Victory Capital Management Inc. increased its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 42.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 58,353 shares of the company’s stock after acquiring an additional 17,377 shares during the quarter. Victory Capital Management Inc.’s holdings in Oscar Health were worth $1,238,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of OSCR. Wealth Enhancement Advisory Services LLC grew its position in Oscar Health by 7.5% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock worth $255,000 after buying an additional 844 shares in the last quarter. American International Group Inc. grew its holdings in shares of Oscar Health by 1.3% during the 1st quarter. American International Group Inc. now owns 79,411 shares of the company’s stock worth $1,181,000 after purchasing an additional 1,009 shares in the last quarter. Summit Trail Advisors LLC increased its position in shares of Oscar Health by 5.4% during the second quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock valued at $329,000 after purchasing an additional 1,065 shares during the period. Arizona State Retirement System increased its position in shares of Oscar Health by 3.7% during the second quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock valued at $602,000 after purchasing an additional 1,351 shares during the period. Finally, Amalgamated Bank raised its stake in shares of Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after purchasing an additional 1,458 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Oscar Health news, Vice Chairman Joshua Kushner bought 276,040 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The stock was acquired at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the purchase, the insider now directly owns 5,031,262 shares of the company’s stock, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Thrive Partners Vii Growth Gp, acquired 420,819 shares of the stock in a transaction dated Tuesday, November 12th. The stock was bought at an average price of $13.68 per share, with a total value of $5,756,803.92. Following the purchase, the director now directly owns 5,452,081 shares in the company, valued at $74,584,468.08. This represents a 8.36 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 1,055,478 shares of company stock valued at $14,432,852 and have sold 194,569 shares valued at $3,433,319. Company insiders own 25.11% of the company’s stock.

Oscar Health Stock Down 3.4 %

Shares of OSCR opened at $16.28 on Wednesday. The firm has a 50 day simple moving average of $17.68 and a two-hundred day simple moving average of $18.11. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health, Inc. has a one year low of $7.29 and a one year high of $23.79. The company has a market cap of $4.03 billion, a P/E ratio of -271.29 and a beta of 1.67.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. During the same quarter in the prior year, the company earned ($0.29) earnings per share. Oscar Health’s revenue for the quarter was up 68.3% compared to the same quarter last year. Research analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently weighed in on OSCR shares. UBS Group assumed coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price on the stock. Piper Sandler restated an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.